FEBRUARY HEADLINES

Novel compound opens new avenue in immunotherapy treatment for cancers

A team of UF Health Cancer Center researchers developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer. In laboratory and mouse testing in skin and colorectal cancer models, the compound slowed the growth of established tumors by unleashing the body’s own immune system to attack cancer cells and, in some cases, eradicated the tumors.

Graphic of novel compound attack cancer cells

Shedding light on melanoma cells’ response to chemotherapy

In a study recently published in Nature Communications, scientists from the Moffitt Cancer Center, in collaboration with the UF Health Cancer Center and the UF Interdisciplinary Center for Biotechnology Research, shed light on a pivotal mechanism regarding melanoma cells’ response to stress induced by chemotherapy agents.

Image of a melanoma cell

Closing the Care Gap

Cancer prevention programs coming to communities across Florida

The UF Health Cancer Center is joining with leading Florida cancer centers — Sylvester Comprehensive Cancer Center at the University of Miami Health System and Moffitt Cancer Center — to fund four grants that will bring cancer prevention and detection education to high-risk Florida communities.

a man checks out a giant inflatable colon designed to raise awareness and provide education on the importance of regular colon screenings